In the largest and most conclusive study of its kind, researchers have analysed blood samples to create a novel and non-invasive way of helping to diagnose Alzheimer’s disease and distinguish between different types of neurodegenerative disorders.
Following this breakthrough discovery, Alzheimer’s sufferers may now have an additional test to improve the accuracy of diagnosis in order to better tailor appropriate treatment.
The research also offers a valuable opportunity to monitor the progression of the disease.
The international study in the Proceedings of the National Academy of Sciences USA used sensor-based technology with a diamond core to analyse approximately 550 blood samples.
By passing light through the diamond and observing its interactions with the blood plasma, researchers were able to identify specific chemical bonds within the blood. This biochemical data was used to compare blood samples from cases of Alzheimer’s disease and other neurodegenerative diseases with those from healthy controls.
The ground-breaking scientific investigation was carried out by researchers at Lancaster University, the University of Central Lancashire (UCLan), the University of Manchester and the Federal University of Rio Grande do Norte, Brazil.
Professor David Allsop from Lancaster University has been collaborating for many years withProfessor David Mann from the University of Manchester in searching for diagnostic markers for neurodegenerative disease in blood plasma.
They provided all of the plasma samples for the study, along with supporting clinical and genetic information, and expertise in Alzheimer’s and other neurodegenerative conditions.
Professor Allsop said: “A particularly exciting aspect of the study was the ability to distinguish accurately between Alzheimer’s disease and Lewy body dementia, which are conditions that both result in dementia and can be difficult to separate from each other based on clinical information and symptoms. By reduction of misdiagnosed cases and administration of appropriate treatment, many people could benefit from this type of blood test in the future.”
Alzheimer’s diagnosis currently involves careful medical evaluation including clinical history, memory testing and brain scans, yet the only conclusive diagnosis is determined by post-mortem examination. This new blood test offers a non-invasive, more accurate and relatively cost-effective method of diagnosis, which will ensure the correct management of the condition.
Professor Francis Martin, principal investigator of the study and Biosciences theme lead at UCLan, said: “We have an aging population, meaning that the incidence and prevalence of Alzheimer’s is increasing, as is the need for accurate diagnosis. The ability to identify different neurodegenerative diseases through the analysis of blood offers a faster and accurate way of establishing the most effective treatment plan as well as disease monitoring.”
This new approach could also offer potential for carrying out tests to identify and monitor early signs of mild cognitive impairment, meaning that the onset of Alzheimer’s and other types of neurodegenerative diseases could be detected early and intervention measures could be put in place earlier to slow the progress of these diseases.
Professor Martin added: “For those suffering with Alzheimer’s disease, the damage is already well advanced once conventionally diagnosed, but this new method offers a potentially effective early screening tool when patients are only demonstrating signs of mild cognitive impairment. This is a potentially significant breakthrough for the prevention of different debilitating and chronic neurological diseases.”
The Latest on: Alzheimer’s
BookBuzz.net and Author Mary Ellen Connelly Promote Memoir - Jum & Muz: I Forget - A Caregivers View of Alzheimers
on May 17, 2018 at 4:20 pm
BookBuzz.net and author Mary Ellen Connelly are pleased to announce the promotion of Connelly's memoir, Jum & Muz: I Forget - a Caregivers View of Alzheimers. This book shows the unrelenting scourge of Alzheimers and how one family coped. San Francisco, CA ... […]
Richard Allen Johnson
on May 16, 2018 at 11:53 pm
Richard Allen Johnson passed away May 14, 2018, at the age of 85 of Alzheimers. He was born April 25, 1933, to Clifford and Iola Johnson in Werner, North Dakota. He moved to Utah, and grew up in Layton and Sunset. He graduated from Davis High School. […]
Significant healthcare challenge ignored in Budget - Alzheimers NZ
on May 16, 2018 at 9:42 pm
Alzheimers NZ is disappointed the Budget does not include enhanced specialist dementia services for the many thousands of Kiwis who have dementia. "Dementia is already one of this country’s greatest healthcare challenges and its impact is only going to ... […]
Ray Wilson, member of England's 1966 World Cup winning side, dies
on May 16, 2018 at 11:17 am
Wilson had bene diagnosed with Alzheimers in 2004. "Everton Football Club is deeply saddened to learn of the passing of Ray Wilson," read a statement on the club website. "Unquestionably one of the finest footballers to wear the royal blue jersey ... […]
Ray Wilson - England World Cup winner in 1966 - dies, aged 83, after battling Alzheimers
on May 16, 2018 at 6:57 am
Ray Wilson has become the third of England’s 1966 World Cup-winning team to die following a long battle against Alzheimer’s Disease. The left-back - oldest member of Sir Alf Ramsey’s team - was not well enough to attend the 50th anniversary dinner ... […]
Global Alzheimers Drugs Market Analysis 2014-2017 & Forecast to 2022 by Drug Class, Distribution Channel and Region - ResearchAndMarkets.com
on May 10, 2018 at 8:12 am
DUBLIN--(BUSINESS WIRE)--May 10, 2018--The "Alzheimers Drugs Market by Drug Class , by Distribution Channel , and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2022" report has been added to ResearchAndMarkets.com's ... […]
Alzheimers Society walks the walk
on May 6, 2018 at 3:16 pm
The Alzheimer Society of BC held its North Shore walk at John Lawson Park, West Vancouver May 6. Volunteers Nicola Tindle and Melina Stokes tape paper forget-me-not flowers to a banner set up for participants to acknowledge those affected by the disease. […]
Alzheimers Coachella Valley ‘Memories Are Made Of This’
on May 5, 2018 at 10:32 am
Alzheimers Coachella Valley ‘Memories Are Made Of This’ “Memories are Made of This” was the first major fundraising event for Alzheimers Coachella Valley. Check out this story on desertsun.com: https://desert.sn/2IfsOTu […]
via Google News and Bing News